Hot Flash Experience in Men With Prostate Cancer: A Concept Analysis

American Cancer Society. (2005). Cancer facts and figures 2005. Retrieved June, 2, 2005, from http://www.cancer.org/downloads/STT/CAFF2005f4PWSecured.pdf

Buchholz, N.P., Mattarelli, G., & Buchholz, M.M. (1994). Post-orchiectomy hot flushes. European Urology, 26, 120-122.

Carpenter, J.S., Andrykowski, M.A., Freedman, R.R., & Munn, R. (1999). Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause, 6, 209-215.

Carpenter, J.S., Elam, J.L., Ridner, S.H., Carney, P.H., Cherry, G.J., & Cucullu, H.L. (2004). Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncology Nursing Forum, 31, 591-598.

Cervenakov, I., Kopecny, M., Jancar, M., Chovan, D., & Mal'a, M. (2000). ‘Hot flush', an unpleasant symptom accompanying antiandrogen therapy of prostatic cancer and its treatment by cyproterone acetate. International Urology and Nephrology, 32, 77-79.

Charig, C.R., & Rundle, J.S. (1989). Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology, 33, 175-178.

Clark, J.A., Wray, N.P., & Ashton, C.M. (2001). Living with treatment decisions: Regrets and quality of life among men treated for metastatic prostate cancer. Journal of Clinical Oncology, 19, 72-80.

Dodd, M., Janson, S., Facione, N., Faucett, J., Froelicher, E.S., Humphreys, J., et al. (2001). Advancing the science of symptom management. Journal of Advanced Nursing, 33, 668-676.

Empson, J.A., & Purdie, D.W. (1999). Effects of sex steroids on sleep. Annals of Medicine, 31, 141-145.

Freedman, R.R., & Krell, W. (1999). Reduced thermoregulatory null zone in postmenopausal women with hot flashes. American Journal of Obstetrics and Gynecology, 18, 66-70.

Frodin, T., Alund, G., & Varenhorst, E. (1985). Measurement of skin blood-flow and water evaporation as a means of objectively assessing hot flushes after orchiectomy in patients with prostatic cancer. Prostate, 7, 203-208.

Gordon, D.L., & Emanuele, M.A. (2003). Hot flashes in patients with hypogonadism and low serum gonadotropin levels. Endocrine Practice, 9, 119-123.

Green, H.J., Pakenham, K.I., Headley, B.C., Yaxley, J., Nicol, D.L., Mactaggart, P.N., et al. (2002). Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: A randomized controlled trial. BJU International, 90, 427-432.

Hammar, M., Frisk, J., Grimas, O., Hook, M., Spetz, A.C., & Wyon, Y. (1999). Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: A pilot study. Journal of Urology, 161, 853-856.

Heinemann, K., & Saad, F. (2003). Sweating attacks: Key symptom in menopausal transition only for women? European Urology, 44, 583-587.

Herr, H.W., & O'Sullivan, M. (2000). Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. Journal of Urology, 163, 1743-1746.

Huggins, C., Stevens, R.E., & Hodges, C.V. (1941). Studies on prostate cancer: II. The effects of castration on advanced carcinoma of the prostate gland. Archives of Surgery, 43, 209-223.

Karling, P., Hammar, M., & Varenhorst, E. (1994). Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma. Journal of Urology, 152, 1170-1173.

Kouriefs, C., Georgiou, M., & Ravi, R. (2002). Hot flushes and prostate cancer: Pathogenesis and treatment. BJU International, 89, 379-383.

Kronenberg, F. (1990). Hot flashes: Epidemiology and physiology. Annals of the New York Academy of Science, 592, 52-86, 123-133.

Lenz, E.R., Pugh, L.C., Milligan, R.A., Gift, A., & Suppe, F. (1997). The middle-range theory of unpleasant symptoms: An update. Advances in Nursing Science, 19, 14-27.

Loprinzi, C.L., Goldberg, R.M., O'Fallon, J.R., Quella, S.K., Miser, A.W., Mynderse, L.A., et al. (1994). Transdermal clonidine for ameliorating post-orchiectomy hot flashes. Journal of Urology, 151, 634-636.

Loprinzi, C.L., Michalak, J.C., Quella, S.K., O'Fallon, J.R., Hatfield, A.K., Nelimark, R.A., et al. (1994). Megestrol acetate for the prevention of hot flashes. New England Journal of Medicine, 331, 347-352.

Loprinzi, C.L., Pisansky, T.M., Fonseca, R., Sloan, J.A., Zahasky, K.M., Quella, S.K., et al. (1998). Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. Journal of Clinical Oncology, 16, 2377-2381.

Matsumoto, A.M. (2002). Andropause: Clinical implications of the decline in serum testosterone levels with aging in men. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 57, M76-M99.

Merriam-Webster, Incorporated. (2005). Merriam-Webster online. Retrieved June 16, 2005 from http://m-w.com

Miller, H.G., & Li, R.M. (2004). Measuring hot flashes: Summary of a National Institutes of Health workshop. Mayo Clinic Proceedings, 79, 777-781.

Molnar, G.W. (1975). Body temperatures during menopausal hot flashes. Journal of Applied Physiology, 38, 499-503.

Parra, R.O., & Gregory, J.G. (1990). Treatment of post-orchiectomy hot flashes with transdermal administration of clonidine. Journal of Urology, 143, 753-754.

Quella, S.K., Loprinzi, C.L., Sloan, J.A., Vaught, N.L., DeKrey, W.L., Fisher, T., et al. (1998). Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer, 82, 1784-1788.

Rhodes, V.A., & Watson, P.M. (1987). Symptom distress—The concept: Past and present. Seminars in Oncology Nursing, 3, 242-247.

Roth, A.J., & Scher, H.I. (1998). Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer. Psycho-Oncology, 7, 129-132.

Schow, D.A., Renfer, L.G., Rozanski, T.A., & Thompson, I.M. (1998). Prevalence of hot flushes during and after neoadjuvant hormonal therapy for localized prostate cancer. Southern Medical Journal, 91, 855-857.

Sculpher, M., Bryan, S., Fry, P., de Winter, P., Payne, H., & Emberton, M. (2004). Patients' preferences for the management of non-metastatic prostate cancer: Discrete choice experiment. BMJ, 328, 382.

Spetz, A.C., Fredriksson, M.G., & Hammar, M.L. (2003). Hot flushes in a male population aged 55, 65, and 75 years, living in the community of Linkoping, Sweden. Menopause, 10(1), 81-87.

Spetz, A.C., Hammar, M., Lindberg, B., Spangberg, A., & Varenhorst, E. (2001). Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate. Journal of Urology, 166, 517-520.

Spetz, A.C., Zetterlund, E.L., Varenhorst, E., & Hammar, M. (2003). Incidence and management of hot flashes in prostate cancer. Journal of Supportive Oncology, 1, 263-272.

Stearns, V., Ullmer, L., Lopez, J.F., Smith, Y., Isaacs, C., & Hayes, D. (2002). Hot flushes. Lancet, 360, 1851-1861.

Tan, R.S., Pu, S.J., & Culberson, J.W. (2004). Role of androgens in mild cognitive impairment and possible interventions during andropause. Medical Hypotheses, 62, 14-18.

Thompson, C.A., Shanafelt, T.D., & Loprinzi, C.L. (2003). Andropause: Symptom management for prostate cancer patients treated with hormonal ablation. Oncologist, 8, 474-487.

van Andel, G., & Kurth, K.H. (2003). The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer. European Urology, 44, 209-214.

van Andel, G., Kurth, K.H., & de Haes, J.C. (1997). Quality of life in patients with prostatic carcinoma: A review and results of a study in N+ disease. Prostate-specific antigen as predictor of quality of life. Urological Research, 25(Suppl. 2), S79-S88.

Vermeulen, A. (1993). The male climacterium. Annals of Medicine, 25, 531-534.

Walker, L.O., & Avant, K.C. (1995). Strategies for theory construction in nursing (3rd ed.). Norwalk, CT: Appleton and Lange.

Walsh, B., & Schiff, I. (1990). Vasomotor flushes. Annals of the New York Academy of Sciences, 592, 346-356, 390-394.